This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
6 Nov 2014

Sartorius Opens New Application Center in Shanghai

Sartorius has officially opened a new application center at its Shanghai office. Among the guests, representatives from the Shanghai government, customers from the biopharmaceutical industry, as well as business partners and the media, attended the opening ceremony.


With a floor space of 240 square meters, or 2600 square feet, the new application center offers ample room for product demonstrations, trial runs and training sessions. At this center, customers from the biopharmaceutical industry can now test the latest Sartorius products for cell cultivation, media and buffer preparation, sterile filtration, cross-flow purification, membrane chromatography, virus clearance and aseptic processing. For laboratory customers, Sartorius showcases its entire range of lab instruments and consumables from balances, moisture analysers, pipettes and water purification systems to filters and products for microbiological testing and quality control.


In his speech, Michael Melingo, member of the Sartorius Group Executive Committee and in charge of marketing, sales and services of Sartorius’ lab business, underlined the importance of Shanghai as a strategic and geographical hub for Sartorius in Asia. “Located close to our customers’ R&D centers in Shanghai and other biotech hotspots like Seoul, Tokyo and Singapore, our application center is the place to be for top scientists to talk about the latest industrial and technological trends.” With the substantial investment in this new application center, Sartorius has further extended its footprint in Asia.


Dr Jörg Lindenblatt, the Senior Vice President of Sales Asia/Pacific for Bioprocess Solutions, emphasised the practical approach of the application center. “Our application center is not just a showroom for our extensive range of lab and bioprocess products. We invite our customers to gain hands-on experience with our
technologies during training and demonstration. By doing this, we can demonstrate the benefits of the high degree of seamless integration of the newest state-of-the-art technology for biotech manufacturing.” Besides being used for demonstration purposes, the new application center will serve as training facility for customers,
distributors and staff.

Related News

  • News Federal judge blocks Colorado's unprecedented price cap on Amgen's Enbrel

    A US federal court has halted Colorado's attempt to impose a US$31,200 annual price cap on Amgen's arthritis drug Enbrel, ruling that the pharmaceutical company would likely suffer irreparable harm. The decision represents a significant blow to...
  • News Protecting life-saving therapies: CPHI Online Podcast Series

    The latest episode of the CPHI Podcast Series dives into a critical challenge facing the pharmaceutical industry: ensuring the integrity of temperature-sensitive medications and biologics through advanced predictive technology.

  • News 2026 Outsourcing Outlook Update - pharma at a crossroads

    The pharmaceutical contract development and manufacturing organisation (CDMO) sector is experiencing unprecedented transformation, driven by evolving therapeutic complexities, geopolitical tensions, and the growing demand for specialised manufacturing ...
  • News Roche maintains German investment commitment whilst rivals scale back

    Pharmaceutical giant Roche has reaffirmed its commitment to investing in Germany, standing firm even as competitors Eli Lilly and Boehringer Ingelheim dramatically reduce their planned investments in response to controversial healthcare reforms.

  • News Women in Pharma: The History of CPHI Women in Japan

    Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive.
  • News EU drafts deal to end essential medicines shortage

    European negotiators have agreed new legislation to tackle persistent shortages of essential medicines by prioritising supply security over price in public procurement and supporting domestic pharmaceutical manufacturing with strategic funding.

  • News Thermo Fisher Scientific offloads microbiology business to PE firm Astorg

    The life sciences giant is divesting its global microbiology unit, which generated $645 million in revenue last year, to the pan-European private equity firm as part of an active portfolio management strategy. The transaction is expected to close in th...
  • News The Shift: Why Sustainability is Moving to the Centre of CPHI Milan 2026

    CPHI Online contributor David Roach takes a look at how conversations around sustainability in the pharmaceutical industry can and must be transformed into actionable deliveries, and what the inaugural CPHI Sustainability Summit means for the industry.